The company has secured contracts worth $1.7M for a recently acquired AI-powered advertising business in its portfolio.

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit margin of ...

Global biopharmaceutical manufacturing firm Rentschler Biopharma will shutter its United Kingdom facility as the ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

The biopharma industry is highly dynamic and competitive. Companies that succeed in it must be able to tackle various aspects, including finances, marketing, regulations, investor relations, ...

Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded formulation ...

AI-related deals in the pharmaceutical sector grew by 14% compared to the same period in 2023. This year, AI is expected to ...

GTB-3650 is GT Biopharma's wholly owned second-generation TriKE. It utilizes camelid nanobody technology, with the potential ...